Analiz zabolevaemosti rakommolochnoy zhelezy s uchetom statusa HER2na territorii Rossiyskoy Federatsii

Analiz zabolevaemosti rakommolochnoy zhelezy s uchetom statusa HER2na territorii Rossiyskoy Federatsii

Bibliographic Details
Main Authors:	V V Ryazhenov, S G Gorokhova
Format:	Article
Language:	Russian
Published:	IP Habib O.N. 2011-09-01
Series:	Современная онкология
Online Access:	https://modernonco.orscience.ru/1815-1434/article/view/29439

Similar Items

Rezul'taty «Epidemiologicheskoy programmy skrininga HER2-statusa u bol'nykh rakom molochnoy zhelezy» v Rossiyskoy Federatsii
by: Georgiy Avraamovich Frank, et al.
Published: (2013-09-01)

Prognozirovanie zabolevaemosti rakom molochnoy zhelezy s vydeleniem populyatsii patsientov s giperekspressiey HER2 v Sibirskom federal'nom okruge
by: V V Ryazhenov, et al.
Published: (2012-09-01)

Na territorii Rossiyskoy FederatsiiGertseptin zaregistrirovan v kachestve terapiirasprostranennoy adenokartsinomy zheludkaili pishchevodno-zheludochnogo perekhodas opukholevoy giperekspressiey HER2
by: - -
Published: (2010-09-01)

Epidemiologiya insul'ta v Rossiyskoy Federatsii
by: V I Skvortsova, et al.
Published: (2005-03-01)

Sostoyanie i razvitie diabetologicheskoy sluzhby v Rossiyskoy Federatsii
by: Ivan Ivanovich Dedov, et al.
Published: (2005-09-01)

Sakharnyy diabet v Rossiyskoy Federatsii: problemy i puti resheniya
by: Ivan Ivanovich Dedov
Published: (1998-03-01)

Regional'nye osobennosti organizatsii dispansernogo nablyudeniya v raznykh sub\"ektakh Rossiyskoy Federatsii
by: L. Yu Drozdova, et al.
Published: (2015-12-01)

Pravitel'stvo Rossiyskoy Federatsii Rasporyazhenie20 marta 2003 g.№357-R
by: - -
Published: (2003-09-01)

KARTOGRAFIChESKIY ANALIZ RASPROSTRANENNOSTI RA I AS NA TERRITORII RF
by: T V Dubinina, et al.
Published: (2002-04-01)

Dobavlenie Zomety (zoledronata)k ad\"yuvantnoy endokrinoterapiiuvelichivaet vyzhivaemost' bol'nykhrannim retseptor-pozitivnym rakommolochnoy zhelezy
by: N V Zhukov
Published: (2010-09-01)

Konsensus rossiyskikh ekspertovpo probleme metabolicheskogo sindromav Rossiyskoy Federatsii: opredelenie,diagnosticheskie kriterii, pervichnayaprofilaktika i lechenie
by: N M Akhmedzhanov, et al.
Published: (2010-06-01)

Opyt primeneniya vysokodoznoy khimioterapii pri retsidiviruyushchem techenii i refrakternykh formakh limfomy Khodzhkina (retrospektivnyy analiz dannykh chetyrekh transplantatsionnykh tsentrov Respubliki Belarus', Rossiyskoy Federatsii i Ukrainy)
by: N V Zhukov, et al.
Published: (2006-03-01)

Lechenie dilatatsionnoy kardiomiopatii v Rossiyskoy Federatsii (po dannym Pervogo registra dilatatsionnoy kardiomiopatii)
by: E. N Alaeva, et al.
Published: (2013-12-01)

Analiz zabolevaemosti sakharnym diabetom 1 tipa u detey Krasnodarskogo kraya
by: I Yu Chernyak, et al.
Published: (2007-06-01)

Epidemiologicheskaya kharakteristika sakharnogo diabeta tipa u detey v Rossiyskoy Federatsii (predvaritel'nye dannye)
by: L N Shcherbacheva, et al.
Published: (2004-09-01)

Zaltrap® (aflibertsept) stanet dostupnym v Rossiyskoy Federatsii dlya lecheniya patsientov s metastaticheskim kolorektal'nym rakom
by: - -
Published: (2015-06-01)

K yubileyu Very Nikolaevny Prilepskoy - doktora meditsinskikh nauk, professora, zasluzhennogo deyatelya nauki Rossiyskoy Federatsii
by: - -
Published: (2014-02-01)

Tayverb/Tyverb (lapatinib) – pervyy dvoynoy anti-ErbB1(EGFR)i anti-ErbB2(HER2)-ingibitor v lechenii mestno-rasprostranennogo i metastaticheskogo raka molochnoy zhelezy zaregistrirovan v Rossiyskoy Federatsii
by: - -
Published: (2008-03-01)

Organizatsionnye i pravovye aspekty stanovleniya sistemy reabilitatsii detey s vrozhdennymi porokami serdtsa v Rossiyskoy Federatsii
by: L. A Bokeriya, et al.
Published: (2015-12-01)

Sravnitel'noe issledovanie opredeleniya HER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
by: L E Zavalishina, et al.
Published: (2009-06-01)

Analiz rezul'tatov vnedreniya Regional'noy rossiyskoy programmy lecheniya pervichno-generalizovannogo i metastaticheskogo raka molochnoy zhelezy v Voronezhskom oblastnom klinicheskom onkologicheskom dispansere
by: N I Chevardov, et al.
Published: (2005-03-01)

Predstaviteli Rossiyskogo onkologicheskogosoobshchestva i Komiteta Soveta Federatsiipo sotsial'noy politike i zdravookhraneniyudogovorilis' sovmestno borot'sya s rakommolochnoy zhelezy v Rossii
by: - -
Published: (2011-12-01)

Otsenka stepeni kompensatsii uglevodnogo obmena i rasprostranennosti diabeticheskikh oslozhneniy u detey v vozraste do 14 let v Rossiyskoy Federatsii
by: Ekaterina Andreevna Andrianova, et al.
Published: (2007-03-01)

Sostoyanie zabolevaemosti, smertnosti i onkologicheskoy pomoshchi pri zlokachestvennykh novoobrazovaniyakh molochnoy zhelezy v Navoiyskoy oblasti Respubliki Uzbekistan
by: I Yu Kudryavtsev, et al.
Published: (2007-03-01)

Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
by: L E Zavalishina, et al.
Published: (2007-06-01)

Kliniko-ekonomicheskiy analiz primeneniya everolimusa (Afinitor) pri metastaticheskom rake pochki s uchetom kolichestva dobavlennykh let zhizni s popravkoy na kachestvo zhizni
by: A S Kolbin, et al.
Published: (2012-06-01)

DINAMIKA ZABOLEVAEMOSTI PODAGROY V G. IRKUTSKE
by: P S Bondareva, et al.
Published: (2005-06-01)

Effektivnost' i bezopasnost' dvukhfaznogo insulina Aspart 30 po dannym lecheniya patsientov s sakharnym diabetom 2 tipa v Rossiyskoy Federatsii: rezul'taty mnogotsentrovogo nablyudatel'nogo issledovaniya
by: Marina Vladimirovna Shestakova, et al.
Published: (2007-09-01)

DINAMIKA REVMATOLOGIChESKOY ZABOLEVAEMOSTI V G. IRKUTSKE
by: Т И Злобина, et al.
Published: (2005-06-01)

Epidemiologicheskaya kharakteristika rezistentnoy i nekontroliruemoy arterial'noy gipertenzii v Rossiyskoy Federatsii(Rossiyskiy registr nekontroliruemoy i rezistentnoy arterial'noy gipertenzii REGATA-PRIMA «REzistentnaya Gipertoniya ArTeriAl'naya - PRichiny I Mekhanizmy rAzvitiya»)
by: I E Chazova, et al.
Published: (2010-09-01)

Filosofijos statusas
by: Justinas Karosas
Published: (2014-09-01)

Rezhimy na osnove Taksotera®v terapii HER-2-pozitivnogo rakamolochnoy zhelezy
by: E V Artamonova
Published: (2011-06-01)

Opredelenie HER2/neu-statusa po gistologicheskomu materialu -est' li prostranstvo dlya diskussii?
by: A M Borbat, et al.
Published: (2011-03-01)

Sravnitel'nyy analiz rezul'tatov obsledovaniya bol'nykh rakom molochnoy zhelezy po dannym rentgenomammograficheskogo i radiotermometricheskogo obsledovaniy
by: L M Burdina, et al.
Published: (2004-03-01)

Prognosticheskoe znachenie adiponektina v opredeleniiserdechno-sosudistoy zabolevaemosti i smertnosti
Published: (2008-09-01)

Opisanie klinicheskikhsluchaev primeneniya kombinatsiys lapatinibom v lecheniiHER2-pozitivnogo rasprostranennogoraka molochnoy zhelezy
by: L V Bolotina, et al.
Published: (2012-03-01)

PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
by: V. V. Ryazhenov, et al.
Published: (2011-06-01)

Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene
by: V V Ryazhenov, et al.
Published: (2016-09-01)

Ispol'zovanie pokazatelya effektivnosti zatrat pri kompleksnoy farmakoekonomicheskoy otsenke dorogostoyashchikh meditsinskikh tekhnologiy. Primer bevatsizumaba
by: V V Ryazhenov, et al.
Published: (2012-09-01)

PHARMACOECONOMIC ANALYSIS OF OLMESARTAN THERAPY IN THE INDIVIDUAL–LEVEL MANAGEMENT OF ARTERIAL HYPERTENSION
by: S. G. Gorokhova, et al.
Published: (2012-08-01)